Ground State Electronic Interactions in Macrocyclic Fullerene Bis-Adducts
cyclic voltammograms were recorded under argon, at room tem-
perature at a scan rate of 0.1 Vs–1. Under these experimental condi-
tions, Fc+/Fc is observed at 0.58 V vs. Ag/AgNO3.
144.0, 143.5, 143.4, 143.3, 143.0, 142.95, 142.9, 142.85, 142.8,
142.75, 142.3, 140.9, 140.0, 137.3, 136.9, 136.8, 136.75, 136.7,
136.1, 135.9, 135.4, 133.7, 133.3, 127.2, 126.9, 111.9, 111.7, 109.55,
109.5, 106.8, 106.7, 105.9, 104.5, 101.5, 101.4, 88.0, 86.3, 68.4, 68.3,
68.1, 68.0, 67.3, 67.0, 66.7, 66.6, 50.0, 49.7, 40.2, 40.1, 31.9, 29.7,
29.6, 29.45, 29.4, 29.3, 26.1, 22.7, 14.1 ppm. MALDI-TOF-MS:
2180.3 (M+, calcd. for C152H134O12N2: 2180.74). C152H134N2O12·
CH2Cl2 (2265.68): calcd. C 81.11, H 6.05, N 1.24; found C 81.55,
H 6.16, N 1.18.
Compound 5:
A mixture of 3 (0.6 g, 4.15 mmol), 4 (0.5 g,
1.66 mmol), PdCl2(PPh3)2 (280 mg, 0.39 mmol) and CuI (150 g,
0.79 mmol) in dry Et3N (10 mL) was stirred at room temperature
under argon for 12 h. The solution was concentrated, taken up in
CH2Cl2 and filtered through a Celite pad. The organic phase was
washed with H2O, dried with MgSO4 filtered and the solvents evap-
orated to dryness. Column chromatography (SiO2, CH2Cl2/hexane,
Compound 10: As described for 5, with 3 (0.2 g, 1.38 mmol), 9
(0.28 g, 0.46 mmol), PdCl2(PPh3)2 (65 mg, 0.09 mmol), CuI (7 mg,
7:3) yielded
5
(0.56 g, 79%). Dark red powder. 1H NMR
(300 MHz, CDCl3): δ = 7.39 (d, J = 7 Hz, 4 H, Ar-H), 6.62 (d, J 0.04 mmol) and PPh3 (18 mg, 0.07 mmol) in THF/Et3N (3:1)
= 7 Hz, 4 H, Ar-H), 3.91 (s, 6 H, OCH3), 3.00 [s, 12 H, N(CH3)2] (4 mL). Two successive column chromatographies (SiO2, CH2Cl2/
ppm. C26H26N2O4 (430.50): calcd. C 72.54, H 6.09, N 6.51; found
C 72.50, H 6.22, N 6.30.
hexane, 1:1) yielded 10 (0.06 g, 18%) as a yellow powder. 1H NMR
(300 MHz, CD2Cl2): δ = 7.68 (s, 2 H, Ar-H), 7.40 (d, J = 8 Hz, 4
H, Ar-H), 6.71 (d, J = 8 Hz, 4 H, Ar-H), 5.07 (s, 4 H, Ar-CH2),
3.03 [s, 12 H, N(CH3)2], 1.18 [m, 42 H, Si(iPr)3] ppm.
C46H68O2N2Si2 (737.23).
Compound 6: A 1.0 solution of DIBAL-H in hexane (1.8 mL,
1.8 mmol) was slowly added to a solution of 5 (150 mg, 0.35 mmol)
in CH2Cl2 (5 mL) at 0 °C. The resulting mixture was stirred for 2 h.
After 4 h, MeOH was added, then water. The resulting mixture was
filtered through Celite and the solvents evaporated. Recrystaliz-
Compound 11: A 1.0 solution of TBAF in THF (0.25 mL,
0.25 mmol) was added to
a stirred solution of 10 (0.06 g,
ation from CH2Cl2/MeOH yielded 6 (90 mg, 69%). Orange powder. 0.08 mmol) in THF (5 mL) at 0 °C under argon. After 4 h, the
1H NMR (300 MHz, CDCl3): δ = 7.34 (d, J = 7 Hz, 4 H, Ar-H),
6.66 (d, J = 7 Hz, 4 H, Ar-H), 4.55 (s, 4 H, CH2), 3.00 [s, 12 H,
N(CH3)2] ppm. C24H26O2N2 (374.48).
solution was concentrated and taken up in CH2Cl2. The organic
layer was washed with H2O, dried with MgSO4, filtered and the
solvents evaporated to dryness. Column chromatography (SiO2,
CH2Cl2) yielded 11 (34 mg, 99%) as a yellow powder. 1H NMR
(300 MHz, CD2Cl2): δ = 7.60 (s, 2 H, Ar-H), 7.43 (d, J = 8 Hz, 4
H, Ar-H), 6.71 (d, J = 8 Hz, 4 H, Ar-H), 4.89 (s, 4 H, Ar-CH2),
3.03 [s, 12 H, N(CH3)2] ppm. C28H28O2N2 (424.54).
Compound 8: DCC (0.18 g, 0.89 mmol) was added to a solution of
6
(0.14 g, 0.37 mmol), 7 (0.53 g, 0.93 mmol), HOBt (23 mg,
0.15 mmol) and DMAP (18 mg, 0.15 mmol) in CH2Cl2 (15 mL) at
0 °C. After 1 h, the mixture was allowed to slowly warm to room
temperature. After 12 h, the mixture was filtered and the solvents
evaporated. Column chromatography (SiO2, CH2Cl2) yielded 8
(0.5 g, 91%). Orange glassy product. 1H NMR (300 MHz, CDCl3):
δ = 7.30 (d, J = 7 Hz, 4 H, Ar-H), 6.58 (d, J = 7 Hz, 4 H, Ar-H),
6.45 (d, J = 2 Hz, 4 H, Ar-H), 6.38 (t, J = 2 Hz, 2 H, Ar-H), 5.12
(s, 4 H, ArCH2), 5.07 (s, 4 H, C=C-CH2), 3.90 (t, J = 6 Hz, 8 H,
Compound 12: As described for 8, with DCC (40 mg, 0.19 mmol),
11 (34 mg, 0.08 mmol),
7 (0.12 g, 0.2 mmol), HOBt (5 mg,
0.03 mmol) and DMAP (4 mg, 0.03 mmol) in CH2Cl2 (10 mL).
Column chromatography (SiO2, CH2Cl2) yielded 12 (0.11 g, 92%)
as a yellow powder. 1H NMR (300 MHz, CDCl3): δ = 7.52 (s, 2 H,
Ar-H), 7.38 (d, J = 8 Hz, 4 H, Ar-H), 6.63 (d, J = 8 Hz, 4 H, Ar-
OCH2), 3.52 [s, 4 H, CH2(C=O)2], 2.97 [s, 12 H, N(CH3)2], 1.73 H), 6.45 (d, J = 2 Hz, 4 H, Ar-H), 6.38 (t, J = 2 Hz, 2 H, Ar-H),
(m, 8 H, OCH2CH2), 1.50–1.26 (m, 72 H, CH2), 0.87 (t, J = 7 Hz, 5.40 (s, 4 H, Ar-CH2), 5.10 (s, 4 H, Ar-CH2), 3.88 (t, J = 6 Hz, 8
12 H, CH2CH3) ppm. 13C NMR (75 MHz, CDCl3): δ = 166.2, H, OCH2), 3.52 [s, 4 H, CH2(C=O)2], 2.99 [s, 12 H, N(CH3)2], 1.75
160.4, 137.3, 132.9, 111.9, 106.3, 101.2, 68.1, 67.2, 65.3, 41.4, 40.2,
31.9, 29.7, 29.65, 29.6, 29.55, 29.4, 29.3, 29.25, 26.0, 22.7,
14.1 ppm. C92H138N2O12 (1464.11): calcd. C 75.47, H 9.50, N 1.91;
found C 75.66, H 9.66, N 1.90.
(m, 8 H, OCH2CH2), 1.50–1.25 (m, 72 H, CH2), 0.88 (t, J = 7 Hz,
12 H, CH2CH3) ppm. 13C NMR (75 MHz, CDCl3): δ = 166.2,
166.2, 160.4, 150.3, 137.2, 135.9, 132.8, 131.2, 122.5, 111.7, 109.2,
106.2, 101.2, 97.9, 84.4, 68.0, 67.1, 65.2, 41.4, 40.1, 31.9, 29.6, 29.6,
29.4, 29.35, 29.2, 26.0, 22.7, 14.1 ppm. C96H140N2O12 (1514.17):
calcd. C 76.15, H 9.32, N 1.85; found C 76.19, H 9.56, N 1.55.
Compound 1: DBU (0.21 mL, 1.36 mmol) was added to a solution
of C60 (0.25 g, 0.34 mmol), I2 (0.19 g, 0.75 mmol) and 8 (0.5 g,
0.34 mmol) in toluene (500 mL) at room temperature under argon.
The solution was stirred for 12 h, filtered through a short plug of
SiO2 and concentrated. Column chromatography (SiO2, CH2Cl2/
hexane, 1:1) followed by gel permeation chromatography (Biorad,
Compound 2: As described for 1, with C60 (52 mg, 0.07 mmol), 12
(0.105 g, 0.07 mmol) DBU (0.05 mL, 0.28 mmol) and I2 (39 mg,
0.15 mmol) in toluene (250 mL) Column chromatography (SiO2,
CH2Cl2/hexane, 1:1) followed by gel permeation chromatography
(Biorad, Biobeads SX1, CH2Cl2) gave 2 (60 mg, 38%) as a brown
Biobeads SX1, CH2Cl2) gave 1 (0.14 g, 19%). Brown glassy prod-
1
uct. H NMR (300 MHz, CDCl3): δ = 7.51 (d, J = 7 Hz, 2 H, Ar- glassy product. 1H NMR (300 MHz, CDCl3): δ = 7.61 (s, 1 H, Ar-
H), 7.37 (d, J = 7 Hz, 2 H, Ar-H), 6.67 (d, J = 7 Hz, 2 H, Ar-H),
H), 7.36 (d, J = 8 Hz, 2 H, Ar-H), 7.34 (s, 1 H, Ar-H), 7.32 (d, J
6.47 (d, J = 7 Hz, 2 H, Ar-H), 6.45 (d, J = 2 Hz, 2 H, Ar-H), 6.41 = 8 Hz, 2 H, Ar-H), 6.63 (broad s, 4 H, Ar-H), 6.60 (d, J = 8 Hz,
(d, J = 2 Hz, 2 H, Ar-H), 6.35 (t, J = 2 Hz, 1 H, Ar-H), 6.29 (t, J 2 H, Ar-H), 6.57 (d, J = 11 Hz, 1 H, Ar-CH), 6.54 (d, J = 8 Hz, 2
= 2 Hz, 1 H, Ar-H), 6.18 (d, J = 11 Hz, 1 H, C=C-CH), 5.55 (d, J H, Ar-H), 6.46 (t, J = 2 Hz, 1 H, Ar-H), 6.45 (t, J = 2 Hz, 1 H,
= 11 Hz, 1 H, C=C-CH), 5.33 (d, J = 11 Hz, 1 H, Ar-CH), 5.27 Ar-H), 5.91 (d, J = 11 Hz, 1 H, Ar-CH), 5.48 (d, J = 11 Hz, 1 H,
(AB, J = 11 Hz, 2 H, Ar-CH2), 5.11 (d, J = 11 Hz, 1 H, Ar-CH), Ar-CH), 5.46 (s, 2 H, Ar-CH2), 5.44 (s, 2 H, Ar-CH2), 4.98 (d, J =
4.75 (d, J = 11 Hz, 1 H, C=C-CH), 3.83 (m, 8 H, OCH2), 3.02 [s, 11 Hz, 1 H, Ar-CH), 3.96 (t, J = 6 Hz, 4 H, OCH2), 3.93 (t, J =
6 H, N(CH3)2], 2.89 [s, 6 H, N(CH3)2], 1.70 (m, 8 H OCH2CH2),
6 Hz, 4 H, OCH2), 2.97 [s, 6 H, N(CH3)2], 2.95 [s, 6 H, N(CH3)2],
1.50–1.26 (m, 72 H, CH2), 0.88 (t, J = 7 Hz, 12 H, CH2CH3) ppm. 1.74 (m, 8 H, OCH2CH2), 1.50–1.24 (m, 72 H, CH2), 0.87 (t, J =
13C NMR (75 MHz, CDCl3): δ = 162.8, 162.7, 162.5, 161.8, 160.35, 7 Hz, 12 H, CH2CH3) ppm. 13C NMR (75 MHz, CDCl3): δ =
160.3, 150.8, 150.5, 148.9, 148.2, 147.4, 147.35, 147.25, 147.2, 164.2, 163.9, 163.85, 163.4, 160.5, 150.4, 150.35, 148.1, 146.9,
145.9, 145.85, 145.8, 145.75, 145.65, 145.6, 145.5, 145.3, 145.3,
146.8, 146.7, 146.4, 146.3, 145.9, 145.8, 145.5, 145.4, 145.3, 145.25,
145.0, 144.95, 144.9, 144.85, 144.6, 144.55, 144.4, 144.1, 144.05, 145.2, 145.1, 145.05, 145.0, 144.95, 144.7, 144.6, 144.5, 144.4,
Eur. J. Org. Chem. 2009, 5779–5787
© 2009 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
5785